Ionis Pharmaceuticals, Inc. 13D and 13G filings for AKCEA THERAPEUTICS INC:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2020-10-13 08:47 am Sale | 2020-10-10 | 13D | AKCEA THERAPEUTICS INC AKCA | IONIS PHARMACEUTICALS INC IONS | 1,000 100.000% | -77,093,682 (-100.00%) | Filing |
| 2020-08-31 07:12 am Unchanged | 2020-08-30 | 13D | AKCEA THERAPEUTICS INC AKCA | IONIS PHARMACEUTICALS INC IONS | 77,094,682 75.900% | 0 (Unchanged) | Filing |